"Dehydroepiandrosterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
| Descriptor ID |
D003687
|
| MeSH Number(s) |
D04.210.500.054.079.429.625 D04.210.500.578.502.400 D06.472.040.502.400 D06.472.334.851.968.952
|
| Concept/Terms |
Dehydroepiandrosterone- Dehydroepiandrosterone
- 5-Androsten-3-beta-hydroxy-17-one
- 5 Androsten 3 beta hydroxy 17 one
- DHEA
- Prasterone
- Androstenolone
- Dehydroisoandrosterone
|
Below are MeSH descriptors whose meaning is more general than "Dehydroepiandrosterone".
Below are MeSH descriptors whose meaning is more specific than "Dehydroepiandrosterone".
This graph shows the total number of publications written about "Dehydroepiandrosterone" by people in this website by year, and whether "Dehydroepiandrosterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dehydroepiandrosterone" by people in Profiles.
-
Disentangling the unique contributions of age, pubertal stage, and pubertal hormones to brain structure in childhood and adolescence. Dev Cogn Neurosci. 2024 Dec; 70:101473.
-
Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic Biol Med. 2009 Aug 01; 47(3):219-28.
-
Dehydroepiandrosterone in systemic lupus erythematosus. Curr Rheumatol Rep. 2008 Aug; 10(4):286-91.
-
Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab. 2008 Feb; 93(2):534-8.
-
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006 Oct 19; 355(16):1647-59.
-
DHEA supplementation: the claims in perspective. Cleve Clin J Med. 2005 Nov; 72(11):965-6, 968, 970-1 passim.
-
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. 2004 Sep; 50(9):2858-68.
-
Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Arthritis Rheum. 2004 Aug 15; 51(4):601-4.
-
Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus. Expert Opin Investig Drugs. 2003 Jun; 12(6):1017-25.
-
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2002 Jul; 46(7):1820-9.